Arix Bioscience PLC (LON:ARIX)

Arix Bioscience PLC (LON:ARIX)


Share Price
147.50 p
Change
0 (0.00 %)
Market Cap
£199.81 m
Proactive Investors - Run By Investors For Investors

Arix Bioscience PLC

Arix Bioscience is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences.

We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks needed to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to...

EPIC: ARIX
Market: LSE:ARIX
52-week High/Low: 209.45p / 137.00p
Sector: Health Care, Equipment & Services
Market Cap: £199.81 m
Website: arixbioscience.com
col 3
col 4
col 5
col 6

Arix Bioscience PLC RNS Announcements

Date Epic Announcement
10/05/2019 ARIX Arix Bioscience Plc - Director/PDMR Shareholding
01/05/2019 ARIX Arix Bioscience Plc - Issue of Ordinary Shares and Total Voting Rights
16/04/2019 ARIX Arix Bioscience Plc - Autolus announces closing of public offering
11/04/2019 ARIX Arix Bioscience Plc - Autolus announces pricing of public offering
09/04/2019 ARIX Arix Bioscience Plc - Autolus announces launch of proposed public offering
02/04/2019 ARIX Arix Bioscience Plc - Aura completes $40 million Series D financing
01/04/2019 ARIX Arix Bioscience Plc - Autolus presents initial AUTO1 data at AACR
28/03/2019 ARIX Arix Bioscience Plc - Board changes
28/03/2019 ARIX Arix Bioscience Plc - Annual Results for the year ended 31 December 2018
26/03/2019 ARIX Arix Bioscience Plc - Autolus hosts R&D day and provides update on AUTO3
20/03/2019 ARIX Arix Bioscience Plc - Notice of Results
18/03/2019 ARIX Arix Bioscience Plc - Arix co-leads $63m Series B investment round for Imara
19/02/2019 ARIX Arix Bioscience Plc - Autolus announces updated results from CARPALL trial
19/02/2019 ARIX Arix Bioscience Plc - Management and Board changes
14/02/2019 ARIX Arix Bioscience Plc - Harpoon closes initial public offering
08/02/2019 ARIX Arix Bioscience Plc - Harpoon prices Nasdaq IPO
01/02/2019 ARIX Arix Bioscience Plc - Total Voting Rights
29/01/2019 ARIX Arix Bioscience Plc - Update on Harpoon proposed IPO in the United States
03/01/2019 ARIX Arix Bioscience Plc - Issue of Ordinary Shares and Total Voting Rights
28/12/2018 ARIX Arix Bioscience Plc - Harpoon announces proposed public offering in the US
11/12/2018 ARIX Arix Bioscience Plc - Arix appoints Dr Christian Schetter as EIR
03/12/2018 ARIX Arix Bioscience Plc - Autolus announces update on AUTO4 and AUTO5 programmes
03/12/2018 ARIX Arix Bioscience Plc - Autolus presents initial AUTO3 clinical data at ASH
15/11/2018 ARIX Arix Bioscience Plc - Positive Phase 1 clinical trial results
12/11/2018 ARIX Arix Bioscience Plc - Arix invests in $70m Harpoon Series C investment round
02/11/2018 ARIX Arix Bioscience Plc - Autolus Therapeutics to Present New Data at the ASH
30/10/2018 ARIX Arix Bioscience Plc - Aura Biosciences reports positive Phase 1b/2 data
24/10/2018 ARIX Arix Bioscience Plc - LogicBio announces closing of initial public offering
19/10/2018 ARIX Arix Bioscience Plc - LogicBio prices Nasdaq IPO
10/10/2018 ARIX Arix Bioscience Plc - Update on LogicBio proposed IPO in the United States

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use